Description
GHK-Cu + KPV pairs the best-known copper peptide with the anti-inflammatory alpha-MSH tripeptide in one lyophilized vial: 50 mg GHK-Cu and 20 mg KPV. It is built for skin and inflammation research where matrix signalling and inflammatory pathways are studied side by side. Pure Peptides Canada supplies it with CAD pricing and tracked shipping from inside Canada.
GHK-Cu + KPV at a glance
- What it is: 50 mg GHK-Cu (copper tripeptide-1) and 20 mg KPV (Lys-Pro-Val) lyophilized together, 70 mg in total.
- Why researchers pair them: GHK-Cu is studied for collagen and matrix synthesis, KPV for damping NF-κB inflammatory signalling. Together they cover the repair and inflammation sides of skin models.
- Why buy it blended: the 5:2 ratio is fixed when the vial is made, so you prepare one vial instead of two.
- Supplied as: sealed lyophilized powder, 50 mg + 20 mg, single vial or box of 10.
- Delivery: ships from inside Canada by tracked Xpresspost in 3–7 days ($25 CAD), or free in 4–12 days on orders over $299.
GHK-Cu · 50 mg
- Gly-His-Lys bound to copper(II)
- Isolated from human plasma in 1973
- Studied for collagen, elastin and gene expression
- Sold alone as GHK-Cu
KPV · 20 mg
- Lys-Pro-Val, alpha-MSH residues 11 to 13
- 342.44 g/mol
- Studied for NF-κB signalling and colitis models
- Sold alone as KPV
Why GHK-Cu and KPV are studied together
Skin and wound research usually has two sides: rebuilding the extracellular matrix and controlling the inflammation that comes with injury. GHK-Cu has a long literature on the first, with cell studies linking it to collagen and glycosaminoglycan production in fibroblasts. KPV is studied on the second, for reducing inflammatory signalling in epithelial and immune cells. Combining them lets researchers look at both processes in one model with a fixed ratio across every replicate.
Each peptide has its own preclinical literature, but this combination has not been tested in controlled human trials. It is a research formulation, not a cosmetic or a medicine.
Testing note: lab reports for this blend are listed on our Lab Testing page. Check that the report names both components before you order. Regulatory status: neither GHK-Cu nor KPV is an authorized drug in Canada, and Health Canada’s April 2026 public advisory on unauthorized injectable peptides names both. We sell this blend strictly as a laboratory reagent for in-vitro research.
Why researchers order this blend from Pure Peptides Canada
Add a vial or a box of 10 above. Orders over $299 ship free across Canada.
See lab resultsGHK-Cu + KPV Blend FAQ
Where can I buy GHK-Cu with KPV in Canada?
Pure Peptides Canada stocks GHK-Cu + KPV as a lyophilized research reagent, 50 mg + 20 mg per vial, shipped from inside Canada by tracked Xpresspost in 3–7 days ($25 CAD), or free in 4–12 days on orders over $299.
How much of each peptide is in a vial?
50 mg of GHK-Cu and 20 mg of KPV, 70 mg in total. The ratio is the same in every vial, including the box of 10.
How is this different from KLOW?
KLOW contains GHK-Cu and KPV plus BPC-157 and TB-500. This blend has only the copper peptide and KPV, for designs focused on skin and inflammation without the repair peptides.
Can I change the ratio?
No. The ratio is fixed at manufacture. If you need different amounts, buy GHK-Cu and KPV separately.
Is this blend approved in Canada?
No. Neither component is an authorized drug in Canada. This blend is sold only as a laboratory reagent for in-vitro research.
Can this blend be used in people or animals?
No. It is for in-vitro laboratory research only and is not a drug, supplement, cosmetic or food. We do not provide dosing or administration information.
For laboratory research use only. Not a drug, supplement, food or cosmetic, not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.